Today, however, researchers believe that, used carefully, mind-altering drugs could help treat poor mental health. Clinical trials of psychedelic-assisted therapies have been ongoing in the UK for ...

it's also a deep dive into the psychedelic underground; and finally, it's an art book — gorgeously illustrated, with lots of very trippy blotter art. Steve talks with Erik about the wildness of ...

Aiming to improve bioavailability and optimize the therapeutic effect of Clearmind’s psychedelic-based treatmentsVancouver, Canada, March 19, ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Mark Haden, vice president of business development at Clearmind ...

The Drug Enforcement Agency currently classifies ... In June, she’ll speak — likely in a keynote slot — at the Psychedelic Science Conference in Denver. “It takes a lot for a senator ...

Researchers are conducting a clinical trial to evaluate RE104, a novel psychedelic drug similar to 'magic mushrooms,' as a ...

According to market research site Fact.MR, the psychedelic drug market is expected to reach a valuation of $603.1 million in 2024. Growing at a 7% compound annual growth rate, the market could hit ...

Emory is poised to expand its research on how MDMA, a psychedelic drug commonly known as ecstasy, could help patients with PTSD when coupled with psychotherapy.

PHOENIX — Arizona lawmakers are moving forward with a bill that would fund clinical trials of a psychedelic drug that could help veterans. House Bill 2871 would appropriate $5 million to fund ...